Risk Factors and Mortality of Elderly Patients with Hospital-Acquired Pneumonia of Carbapenem-Resistant Klebsiella pneumoniae Infection

References

• Torres A, Niederman MS, Chastre J, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT). Eur Respir J. 2017:50. doi:10.1183/13993003.00582-2017
   Google Scholar
• American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388–416. doi:10.1164/rccm.200405-644ST
   PubMed Web of Science ®Google Scholar
• Tao XB, Qian LH, Li Y, et al. Hospital-acquired infection rate in a tertiary care teaching hospital in China: a cross-sectional survey involving 2434 inpatients. Int J Infect Dis. 2014;27:7–9. doi:10.1016/j.ijid.2014.05.011
   PubMed Web of Science ®Google Scholar
• Zhu J, Zhang X, Shi G, Yi K, Tan X, Chamberlain AM. Atrial fibrillation is an independent risk factor for hospital-acquired pneumonia. PLoS One. 2015;10(7):e0131782. doi:10.1371/journal.pone.0131782
   PubMed Web of Science ®Google Scholar
• Russo TA, Marr CM. Hypervirulent Klebsiella pneumoniae. Clin Microbiol Rev. 2019;32. doi:10.1128/cmr.00001-19
   Web of Science ®Google Scholar
• Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8(3):159–166. doi:10.1016/s1473-3099(08)70041-0
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327. doi:10.1016/s1473-3099(17)30753-3
   PubMed Web of Science ®Google Scholar
• Chen IR, Huang PH, Wu PF, Wang FD, Lin YT. Clinical characteristics and outcomes of 56 patients with pneumonia caused by carbapenem-resistant Klebsiella pneumoniae. J Glob Antimicrob Resist. 2021;25:326–330. doi:10.1016/j.jgar.2021.03.028
   PubMed Web of Science ®Google Scholar
• Chen IR, Lin SN, Wu XN, Chou SH, Wang FD, Lin YT. Clinical and microbiological characteristics of bacteremic pneumonia caused by Klebsiella pneumoniae. Front Cell Infect Microbiol. 2022;12:903682. doi:10.3389/fcimb.2022.903682
   PubMed Web of Science ®Google Scholar
• Wang Z, Qin RR, Huang L, Sun LY. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection and mortality of Klebsiella pneumoniae infection. Chin Med J. 2018;131(1):56–62. doi:10.4103/0366-6999.221267
   PubMed Web of Science ®Google Scholar
• Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother. 2008;52(3):1028–1033. doi:10.1128/aac.01020-07
   PubMed Web of Science ®Google Scholar
• Debby BD, Ganor O, Yasmin M, et al. Epidemiology of carbapenem resistant Klebsiella pneumoniae colonization in an intensive care unit. Eur J Clin Microbiol Infect Dis. 2012;31(8):1811–1817. doi:10.1007/s10096-011-1506-5
   PubMed Web of Science ®Google Scholar
• Qin X, Wu S, Hao M, et al. The colonization of carbapenem-resistant Klebsiella pneumoniae: epidemiology, resistance mechanisms, and risk factors in patients admitted to intensive care units in China. J Infect Dis. 2020;221(Supplement_2):S206–S214. doi:10.1093/infdis/jiz622
   PubMedGoogle Scholar
• van Duin D, Perez F, Rudin SD, et al. Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network. Antimicrob Agents Chemother. 2014;58(7):4035–4041. doi:10.1128/aac.02636-14
   PubMed Web of Science ®Google Scholar
• Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–1139. doi:10.1097/01.mlr.0000182534.19832.83
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• Henderson H, Luterbach CL, Cober E, et al. The Pitt bacteremia score predicts mortality in nonbacteremic infections. Clin Infect Dis. 2020;70(9):1826–1833. doi:10.1093/cid/ciz528
   PubMed Web of Science ®Google Scholar
• Ramirez JA, Musher DM, Evans SE, et al. Treatment of community-acquired pneumonia in immunocompromised adults: a consensus statement regarding initial strategies. Chest. 2020;158(5):1896–1911. doi:10.1016/j.chest.2020.05.598
   PubMed Web of Science ®Google Scholar
• Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27–S72. doi:10.1086/511159
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Trecarichi EM, Corona A, et al. Efficacy of ceftazidime-avibactam salvage therapy in patients with infections caused by Klebsiella pneumoniae Carbapenemase–producing K. pneumoniae. Clin Infect Dis. 2019;68(3):355–364. doi:10.1093/cid/ciy492
   PubMed Web of Science ®Google Scholar
• Fang J, Li H, Zhang M, et al. Efficacy of ceftazidime-avibactam versus polymyxin B and risk factors affecting clinical outcomes in patients with carbapenem-resistant Klebsiella pneumoniae infections a retrospective study. Front Pharmacol. 2021;12:780940. doi:10.3389/fphar.2021.780940
   PubMed Web of Science ®Google Scholar
• Lu J, Zhang A, Han L, et al. Clinical outcomes and risk factors for death following carbapenem-resistant Klebsiella pneumoniae infection in solid organ transplant recipients. Microbiol Spectr. 2023;11(1):e0475522. doi:10.1128/spectrum.04755-22
   PubMed Web of Science ®Google Scholar
• Croxatto A, Prod’hom G, Greub G. Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. FEMS Microbiol Rev. 2012;36(2):380–407. doi:10.1111/j.1574-6976.2011.00298.x
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute W, PA. Performance Standards for Antimicrobial Susceptibility Testing, M100. 31st ed. Clinical and Laboratory Standards Institute; 2021.
   Google Scholar
• Pang F, Jia XQ, Zhao QG, Zhang Y. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals. Ann Clin Microbiol Antimicrob. 2018;17(1):13. doi:10.1186/s12941-018-0267-8
   PubMed Web of Science ®Google Scholar
• Zuo Y, Zhao D, Song G, Li J, Xu Y, Wang Z. Risk factors, molecular epidemiology, and outcomes of carbapenem-resistant Klebsiella pneumoniae infection for hospital-acquired pneumonia: a matched case-control study in eastern china during 2015–2017. Microb Drug Resist. 2021;27(2):204–211. doi:10.1089/mdr.2020.0162
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen Y, Liu P, et al. Risk factors and mortality for elderly patients with bloodstream infection of carbapenem resistance Klebsiella pneumoniae: a 10-year longitudinal study. BMC Geriatr. 2022;22(1):573. doi:10.1186/s12877-022-03275-1
   PubMed Web of Science ®Google Scholar
• Chen J, Ma H, Huang X, et al. Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study. Antimicrob Resist Infect Control. 2022;11(1):161. doi:10.1186/s13756-022-01204-w
   PubMed Web of Science ®Google Scholar
• Cao Z, Yue C, Kong Q, Liu Y, Li J. Risk factors for a hospital-acquired carbapenem-resistant Klebsiella pneumoniae bloodstream infection: a five-year retrospective study. Infect Drug Resist. 2022;15:641–654. doi:10.2147/idr.S342103
   PubMed Web of Science ®Google Scholar
• Hsu JY, Chuang YC, Wang JT, Chen YC, Hsieh SM. Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: risk factors, mortality, and antimicrobial susceptibility, 2017–2019. J Formos Med Assoc. 2021;120(11):1994–2002. doi:10.1016/j.jfma.2021.04.014
   PubMed Web of Science ®Google Scholar
• Pollack M, Charache P, Nieman RE, Jett MP, Reimhardt JA, Hardy PH. Factors influencing colonisation and antibiotic-resistance patterns of gram-negative bacteria in hospital patients. Lancet. 1972;2(7779):668–671. doi:10.1016/s0140-6736(72)92084-3
   PubMed Web of Science ®Google Scholar
• Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998;11(4):589–603. doi:10.1128/cmr.11.4.589
   PubMed Web of Science ®Google Scholar
• Gorrie CL, Mirceta M, Wick RR, et al. Gastrointestinal carriage is a major reservoir of Klebsiella pneumoniae infection in intensive care patients. Clin Infect Dis. 2017;65(2):208–215. doi:10.1093/cid/cix270
   PubMed Web of Science ®Google Scholar
• Yin Y, Zhao C, Li H, et al. Clinical and microbiological characteristics of adults with hospital-acquired pneumonia: a 10-year prospective observational study in China. Eur J Clin Microbiol Infect Dis. 2021;40(4):683–690. doi:10.1007/s10096-020-04046-9
   PubMed Web of Science ®Google Scholar
• Santella B, Serretiello E, De Filippis A, et al. Lower respiratory tract pathogens and their antimicrobial susceptibility pattern: a 5-year study. Antibiotics. 2021;10(7):851. doi:10.3390/antibiotics10070851
   Google Scholar
• Cheng WL, Hsueh PR, Lee CC, et al. Bacteremic pneumonia caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: appropriateness of empirical treatment matters. J Microbiol Immunol Infect. 2016;49(2):208–215. doi:10.1016/j.jmii.2014.05.003
   PubMedGoogle Scholar
• Nicasio AM, Crandon JL, Nicolau DP. In vivo pharmacodynamic profile of tigecycline against phenotypically diverse Escherichia coli and Klebsiella pneumoniae isolates. Antimicrob Agents Chemother. 2009;53(7):2756–2761. doi:10.1128/aac.01678-08
   PubMed Web of Science ®Google Scholar
• Xu L, Wang YL, Du S, Chen L, Long LH, Wu Y. Efficacy and safety of tigecycline for patients with hospital-acquired pneumonia. Chemotherapy. 2016;61(6):323–330. doi:10.1159/000445425
   PubMed Web of Science ®Google Scholar
• Karampatakis T, Tsergouli K, Behzadi P. Carbapenem-resistant Klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options. Antibiotics. 2023;12(2):234. doi:10.3390/antibiotics12020234
   Google Scholar
• Ahmadi Z, Noormohammadi Z, Behzadi P, Ranjbar R. Molecular detection of gyrA mutation in clinical strains of Klebsiella pneumoniae. Iran J Public Health. 2022;51(10):2334–2339. doi:10.18502/ijph.v51i10.10992
   PubMed Web of Science ®Google Scholar
• Behzadi P, García-Perdomo HA, Karpiński TM, Issakhanian L. Metallo-ß-lactamases: a review. Mol Biol Rep. 2020;47(8):6281–6294. doi:10.1007/s11033-020-05651-9
   PubMed Web of Science ®Google Scholar
• Fasciana T, Gentile B, Aquilina M, et al. Co-existence of virulence factors and antibiotic resistance in new Klebsiella pneumoniae clones emerging in south of Italy. BMC Infect Dis. 2019;19(1):928. doi:10.1186/s12879-019-4565-3
   PubMed Web of Science ®Google Scholar
• Algammal A, Hetta HF, Mabrok M, Behzadi P. Editorial: emerging multidrug-resistant bacterial pathogens “superbugs”: a rising public health threat. Front Microbiol. 2023;14:1135614. doi:10.3389/fmicb.2023.1135614
   PubMed Web of Science ®Google Scholar
• Ahmadi M, Ranjbar R, Behzadi P, Mohammadian T. Virulence factors, antibiotic resistance patterns, and molecular types of clinical isolates of Klebsiella Pneumoniae. Expert Rev Anti Infect Ther. 2022;20(3):463–472. doi:10.1080/14787210.2022.1990040
   PubMed Web of Science ®Google Scholar
• Fasciana T, Ciammaruconi A, Gentile B, et al. Draft genome sequence and biofilm production of a carbapenemase-producing Klebsiella pneumoniae (KpR405) sequence type 405 strain isolated in Italy. Antibiotics. 2021;10(5):560. doi:10.3390/antibiotics10050560
   Web of Science ®Google Scholar
• Falsetti L, Martino M, Zaccone V, et al. SOFA and qSOFA usefulness for in-hospital death prediction of elderly patients admitted for suspected infection in internal medicine. Infection. 2020;48(6):879–887. doi:10.1007/s15010-020-01494-5
   PubMed Web of Science ®Google Scholar